Female; 57 years old. Reason: Brachytherapy planning History: Brachytherapy planning PELVIS:UTERUS, ADNEXA: Cervical mass, compatible with the known cervical cancer, demonstrating intermediate T2 signal, restricted diffusion, and increased enhancement. The mass measures up to approximately 2.8 x 4.6 x 4.3 cm (AP by transverse by craniocaudal, sagittal series 601/35 and axial series 401/18). There is mild anterior and bilateral parametrial invasion, right greater than left (series 41/19 and series 1109/325), mild invasion of the tumor into the lower uterine segment and the myometrium, mild invasion into the anterior vaginal cuff (series 601/33), mild invasion into the posterior superior bladder wall (series 601/33), and abutment of but no definite invasion into the rectum.BLADDER: As above.LYMPH NODES: Subcentimeter pelvic sidewall lymph nodes are not enlarged by size criteria. Prominent bilateral inguinal lymph nodes, which were not FDG avid on prior study.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: Moderate amount of pelvic ascites.
Cervical cancer with invasion into surrounding structures as detailed above.